News
HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target
30 May 24
News, Price Target, Reiteration, Analyst Ratings
Milestone Pharmaceuticals Upgraded to Buy: Here's What You Should Know
16 May 24
News, Penny Stocks, Upgrades, Markets, Analyst Ratings, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target
16 May 24
News, Price Target, Reiteration, Analyst Ratings
Milestone Pharmaceuticals To Present Data On Etripamil At The Preventative Cardiovascular Nursing Symposium
17 Apr 24
Biotech, News, General
Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients' Ability To Self-Manage Recurring PSVT, Presented At The American College Of Cardiology Annual Meeting
8 Apr 24
Biotech, News, General
Milestone Pharmaceuticals To Present Data On Etripamil At The American College Of Cardiology And European Heart Rhythm Association Annual Conferences
1 Apr 24
Biotech, News, General
Press releases
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
31 May 24
News, Press Releases
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
13 May 24
Earnings, Press Releases
Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium
17 Apr 24
News, Health Care, Press Releases
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients' Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting
8 Apr 24
Press Releases